Advanced Search

 

Study ID Status Title Patient Level Data
109563 Completed COMPAS: A phase III study to demonstrate efficacy of GSK Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media Study Listed on ClinicalStudyDataRequest.com
109609 Terminated A Phase II, Non-randomized, Multi-center Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) in Subjects with Advanced Non-Small Cell Lung Cancer
109616 (Y7) Completed Follow-up study to evaluate the long-term efficacy of a HPV vaccine (580299) in healthy young adult women in Brazil Study Listed on ClinicalStudyDataRequest.com
109621 Completed Safety, reactogenicity and immunogenicity following booster dose of GSK Biologicals´ pneumococcal conjugate vaccine when co-administered with a booster dose of Infanrix-IPV/Hib in preterm born children at 16-18 months of age Study Listed on ClinicalStudyDataRequest.com
109628 Completed Safety and immunogenicity study of an additional dose of HPV vaccine (580299) in young, adult women in North America. Study Listed on ClinicalStudyDataRequest.com
109630 Completed Assess the consistency of the immunogenicity of a GlaxoSmithKline Biologicals' pandemic influenza vaccine (GSK1562902A) in adults aged between 18 and 60 years Study Listed on ClinicalStudyDataRequest.com
109652 Completed A single-centre open label study to investigate the effect of repeat doses of SB-649868 on the pharmacokinetics of Simvastatin and Atorvastatin in healthy male volunteers. Study Listed on ClinicalStudyDataRequest.com
109661 Completed Primary vaccination course in children receiving the pneumococcal vaccine GSK 1024850A, Infanrix hexa and Rotarix Study Listed on ClinicalStudyDataRequest.com
109664 Completed Assessment of long-term antibody persistence after a booster dose of GSK Biologicals’ Hib & meningococcal C vaccine (Menitorix™) 811936 given at 12-15 months of age to subjects primed with 3 doses of Menitorix™ at 2, 3, 4 months of age Study Listed on ClinicalStudyDataRequest.com
109705 Completed Study of two formulations of GSK Biologicals' varicella vaccine given as a 2-dose course in the second year of life Study Listed on ClinicalStudyDataRequest.com
109710 Completed A single-blind, randomized, placebo controlled, two-period crossover fMRI study to investigate the effects of the D3 antagonist GSK598809 on neural and behavioural responses to food reward and reinforcement after a single oral dose of GSK598809 in overweight and obese subjects. Study Listed on ClinicalStudyDataRequest.com
109731 Completed An adaptive PET study in healthy volunteers using [11C]GSK931145 to establish the relationship of Glycine Transporter 1 occupancy by GSK1018921 to plasma concentrations over time. Study Listed on ClinicalStudyDataRequest.com
109801 Completed Complementary testing to further evaluate the immunogenicity of a GSK Biologicals’ HPV vaccine (580299) in healthy female subjects aged over 26 years enrolled in study 104820. Study Listed on ClinicalStudyDataRequest.com
109810 Completed To assess long-term efficacy & safety of subjects approximately 3 years after priming with 2 doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) vaccine (Rotarix) in the primary vaccination study (102247). Study Listed on ClinicalStudyDataRequest.com
109817 Completed Evaluate the reactogenicity & immunogenicity of 1 or 2 booster administrations of an influenza pandemic candidate vaccine (GSK1562902A) in primed adults aged between 19 & 61 years Study Listed on ClinicalStudyDataRequest.com
109821 Completed Observer blind study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals influenza vaccine GSK576389A administered to adults over 65 years previously vaccinated with the same vaccine, compared to Fluarix™ Study Listed on ClinicalStudyDataRequest.com
109825 Safety and immunogenicity of GSK Biologicals’ (pre-) pandemic influenza candidate vaccine (GSK1562902A) in children aged 6 to 35 months Study Listed on ClinicalStudyDataRequest.com
109836 Completed A multicentre study to evaluate the safety and immunogenicity of GSK Biologicals’ HPV vaccine (GSK1674330A) in healthy female subjects aged 18–25 years. Study Listed on ClinicalStudyDataRequest.com
109861 Completed Primary vaccination course in children receiving the pneumococcal vaccine GSK 1024850A, Infanrix hexa and Rotarix Study Listed on ClinicalStudyDataRequest.com
109995 Completed A phase IIIb, open, randomised, multicentre, primary study in healthy children, to establish the non-inferiority of GlaxoSmithKline (GSK) Biologicals’ MeMuRu-OKA vaccine (administered at 9 and 15 months of age) versus Priorix™ (9 months of age) and Priorix™ co-administered with Varilrix™ at 15 months of age (comparator) and also to evaluate the non-inferiority of Priorix™ (9 months of age) and MeMuRu-OKA vaccine (15 months of age) versus the comparator, all administered subcutaneously as two-dos Study Listed on ClinicalStudyDataRequest.com
110028 Completed A Phase I/II, Observer-Blind, Randomized, Active-Controlled Trial to Evaluate the Safety and Immunogenicity of a Two-Dose Series of GSK Biologicals' Candidate Influenza Vaccine GSK 1557484A Antigens With or Without Adjuvant Study Listed on ClinicalStudyDataRequest.com
110031 Completed Phase II, observer-blind follow-up study to assess reacto-and immunogenicity of GSK Biologicals' pneumococcal conjugate vaccine (GSK1024850A), when given as booster in primed children or as 2-dose catch-up in unprimed children. Study Listed on ClinicalStudyDataRequest.com
110040 Completed A single-blind, randomised, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of intravenously infused GSK1070806 in healthy and obese subjects. Study Listed on ClinicalStudyDataRequest.com
110058 Completed Immunogenicity of GlaxoSmithKline Biologicals' MMRV vaccine (208136) vs. ProQuad®, when coadministered with hepatitis A and pneumococcal conjugate vaccines to children 12-14 months of age. Study Listed on ClinicalStudyDataRequest.com
110058 Completed Immunogenicity of GlaxoSmithKline Biologicals' MMRV vaccine (208136) vs. ProQuad®, when coadministered with hepatitis A and pneumococcal conjugate vaccines to children 12-14 months of age. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.